The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.

Risk warning:

Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.

Today's key assessments and concerns

Cantor Fitzgerald: Maintaining an "overweight" rating on Ultragenyx Pharmaceutical ( Ultragenyx Pharmaceutical, Inc.(RARE.US) ), while raising the price target from $84 to $96.

Ascendiant Capital: Maintaining a "buy" rating on Liqtech International ( LiqTech International, Inc.(LIQT.US) ), while raising the price target from $4.3 to $4.4.

Baird: Maintaining an "outperform" rating for NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $300 to $500.

Stifel: A preliminary rating of "Buy" for Eupraxia Pharmaceuticals ( Eupraxia Pharmaceuticals, Inc.(EPRX.US) ), with a target price of $25.

Needham: Maintaining a "buy" rating on Streamex ( Streamex Corp.(STEX.US) ), while lowering the price target from $9 to $8.

The symbol	Classification	Target price	Current price	Percentage of potential increase/decrease	(Classification) Agency
Ultragenyx Pharmaceutical, Inc.(RARE.US)	to lift	$96.0	$23.71	304.89%	Cantor Fitzgerald
LiqTech International, Inc.(LIQT.US)	to lift	$4.4	$1.83	140.44%	Ascendiant Capital
NVIDIA Corporation(NVDA.US)	to lift	$500.0	$219.51	127.78%	Baird
Rapport Therapeutics(RAPP.US)	to lift	$65.0	$36.7	77.11%	BTIG
NVIDIA Corporation(NVDA.US)	to lift	$350.0	$219.51	59.45%	B of A Securities
Eupraxia Pharmaceuticals, Inc.(EPRX.US)	Initial classification	$25.0	$6.94	260.23%	Stifel
Streamex Corp.(STEX.US)	cut	$8.0	$1.13	607.96%	Needham
Nouveau Monde Graphite Inc(NMG.US)	cut	$4.5	$1.97	128.43%	HC Wainwright & Co.
Intuit Inc.(INTU.US)	cut	$591.0	$307.07	92.46%	Citigroup
Compugen Ltd.(CGEN.US)	cut	$5.0	$2.61	91.57%	Leerink Partners

comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)

Lifting

Lake Street: Maintaining a "buy" rating on Applied Digital ( Applied Digital(APLD.US) ), while raising the price target from $55 to $70.

Needham: Maintaining a "buy" rating on Applied Digital ( Applied Digital(APLD.US) ), while raising the price target from $51 to $66.

Morgan Stanley: Maintaining an "underweight" rating on Dell Dell Technologies, Inc. Class C(DELL.US) stock, while raising the price target from $110 to $170.

Morgan Stanley: Maintaining HP's ( HP Inc.(HPQ.US) ) rating at "underweight", while raising the price target from $16 to $17.

Barclays: Maintaining an "overweight" rating on Coca-Cola Coca-Cola Company(KO.US) , while raising its price target from $85 to $89.

Citigroup: Maintaining a "buy" rating on Marvell Technology ( Marvell Technology, Inc.(MRVL.US) ), while raising the price target from $118 to $215.

Needham: Maintaining a "buy" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $240 to $270.

JP Morgan: Maintaining an "overweight" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $265 to $280.

Morgan Stanley: Maintaining an "overweight" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising the price target from $285 to $288.

Wedbush: Maintaining its "Outperform Market" rating for NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising its price target from $300 to $330.

First Coverage

Cantor Fitzgerald: Initial rating for Aligos Therapeutics ( Aligos Therapeutics, Inc.(ALGS.US) ) at "overweight", with a price target of $20.

Cantor Fitzgerald: Initial rating for Connect Biopharma Holdings Ltd.(CNTB.US) stock at "overweight", with a target price of $4.

Leerink Partners: Initial rating for Opus Genetics ( Opus Genetics, Inc.(IRD.US) ) at "outperforms the market", with a price target of $10.

Craig-Hallum: Initial rating for MapLight Therapeutics ( MapLight Therapeutics, Inc.(MPLT.US) ) at "Buy", with a target price of $43.

Roth Capital: Initial rating for SailPoint ( SailPoint, Inc.(SAIL.US) ) stock at "Buy", with a target price of $19.

reduction

Truist Securities: Maintaining a "buy" rating on Intuit ( Intuit Inc.(INTU.US) ) stock, while lowering the price target from $500 to $410.

DA Davidson: Maintaining a "neutral" rating on Lowe's ( Lowe's Companies, Inc.(LOW.US) ), with a price target cut from $275 to $245.

UBS: Maintaining a "buy" rating on Toll Brothers Toll Brothers, Inc.(TOL.US) stock, while lowering the price target from $198 to $187.

Morgan Stanley: Maintaining ELF ( e.l.f. Beauty, Inc.(ELF.US) ) rating at "market-weighted", while lowering the target price from $67 to $59.

Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.